ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ADELINA VORPERIAN MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

4,310Medicare Part D Prescriptions Filled, Including Refills

Rank: 3179 out of 6645

$356K Total Retail Price of All Prescriptions

Rank: 1999 out of 6645

148 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 148 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 3,817 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NEXIUM 142 119 1 40
AMLODIPINE BESYLATE 134 108 2 2
ZOLPIDEM TARTRATE 105 97 3 17
OMEPRAZOLE 104 93 4 6
SIMVASTATIN 102 95 5 1
LIDODERM 97 73 6 53
ALENDRONATE SODIUM 94 91 7 14
ADVAIR DISKUS 93 72 8 45
ATORVASTATIN CALCIUM 92 73 9 10
METFORMIN HCL 83 79 10 7
IBUPROFEN 79 78 11 42
VOLTAREN 79 76 11 108
AZITHROMYCIN 78 63 13 44
GLIMEPIRIDE 76 72 14 47
DIOVAN HCT 68 52 15 64
MELOXICAM 67 67 16 46
METOPROLOL TARTRATE 64 50 17 13
DONEPEZIL HCL 64 63 17 27
CRESTOR 63 61 19 34
TRAMADOL HCL 63 48 19 30
FAMOTIDINE 60 60 21 33
ATENOLOL 59 48 22 8
LOSARTAN-HYDROCHLOROTHIAZIDE 55 52 23 62
ACTONEL 55 45 23 92
LOVAZA 52 40 25 68
EXELON 51 51 26 149
ZETIA 51 32 26 87
DICLOFENAC SODIUM 51 43 26 109
FLUOCINONIDE 50 50 29 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.